• 제목/요약/키워드: Intravenous(IV) injection

검색결과 67건 처리시간 0.034초

The analgesic efficacy of a single injection of ultrasound-guided retrolaminar paravertebral block for breast surgery: a prospective, randomized, double-blinded study

  • Hwang, Boo-Young;Kim, Eunsoo;Kwon, Jae-young;Lee, Ji-youn;Lee, Dowon;Park, Eun Ji;Kang, Taewoo
    • The Korean Journal of Pain
    • /
    • 제33권4호
    • /
    • pp.378-385
    • /
    • 2020
  • Background: The thoracic paravertebral block is an effective analgesic technique for postoperative pain management after breast surgery. The ultrasound-guided retrolaminar block (RLB) is a safer alternative to conventional paravertebral block. Thus, we assessed the analgesic efficacy of ultrasound-guided RLB for postoperative pain management after breast surgery. Methods: Patients requiring breast surgery were randomly allocated to group C (retrolaminar injection with saline) and group R (RLB with local anesthetic mixture). The RLB was performed at the level of T3 with local anesthetic mixture (0.75% ropivacaine 20 mL + 2% lidocaine 10 mL) under general anesthesia before the skin incision. The primary outcome was cumulative morphine consumption using intravenous patient-controlled analgesia (IV-PCA) at 24 hour postoperatively. The secondary outcomes were the visual analogue scale (VAS) scores at 1, 6, 24, and 48 hour postoperatively and the occurrence of adverse events and patient satisfaction after the surgery. Results: Forty-six patients were included, 24 in group C and 22 in group R. The cumulative morphine consumption using IV-PCA did not differ between the two groups (P = 0.631). The intraoperative use of remifentanil was higher in group C than in group R (P = 0.025). The resting and coughing VAS scores at 1 hour postoperatively were higher in group R than in group C (P = 0.011, P = 0.004). The incidence of adverse events and patient satisfaction was not significantly different between the two groups. Conclusions: A single injection of ultrasound-guided RLB did not reduce postoperative analgesic requirements following breast surgery.

개의 치석제거를 위한 마취에 있어 Ketamine HCl/Propionyl promazine HCI과 Tiletamine HCl/Zolazepam HCl의 투여효과 (Analgesic Effect of Combination of Ketamine Hcl/Propionyl promazine HCI and Tiletamine HC1/Zolazepam HCl for Scaling in Dog)

  • 신남식;최윤주;권수완;한덕환;박현종;권오경
    • 한국임상수의학회지
    • /
    • 제10권2호
    • /
    • pp.221-226
    • /
    • 1993
  • To study effective dossage and administration route for scaling, ketamine HCl/propionyl promazine HCl(ketamine) combination and tiletamine HCl/zolazepam HCl(zoletil) were administered in one hundred six dogs. The dogs were toy poodle, Yorkshire Terrier, Pekingese and Chihuahua. Scaling and polishing time, possible treatment time after the first injection of anesthetics, the number of anethesia added, presence of tongue movement during anesthesia, the presence of swaying sign during recovery and respiration were evaluated. The possible treatment time after the first Injection of anesthetic in toy poodle were 26.3${\pm}$3.0 minutes with intravenous(IM) treatment of ketamine 10mg/kg, and 21.4${\pm}$6.6 minutes with intramuscula(IM) treatment of zoletil 8mg/kg, In Yorkshire Terrier were 19.51: 1.7 minutes with IV treatment of ketamine 10mg/kg. 19.0${\pm}$5.2 minutes IM and 20.8${\pm}$6.1 minutes with IM treatment of zoletil 5mg/kg,24.8${\pm}$3,5 minutes with IM treatment of zoletil 8mg/kg. In pekingese were 27.5${\pm}$2.1 minutes with IM treatment of ketamine 10mg/kg,28.0${\pm}$4.2 minutes with IM treatment of zoletil 8mg/kg. In Chihuahua were 19.5${\pm}$1.9 minutes with IV treatment of ketamine 7mg/kg, 17.5${\pm}$1.7 minutes with IM treatment of ketamine 10mg/kg and 20.3${\pm}$3.8 minutes with IM treatment of zoletil 5mg/kg, 21.2${\pm}$5.5 minutes with IM treatment of zoletil 8mg/kg. Swaying sign was observed in all group during recovery time, espically, in toy poodle and Yorkshire Terrier which administered zoletil 8mg/kg IM showed more severe swaying sign. The present results suggested that injection of zoletil 8mg/kg IM might be relatively effective for scaling in Chihuahua Within 20 minutes treatment for scaling in Yorkshire Terrier and Chihuahua, IM treatment of ketamine 7 to 10mg/kg is recommended.

  • PDF

모르핀내성시 뇌실내 NO 합성억제제 투여가 모르핀의 진통효과에 미치는 형향 (Supraspinal Nitric Oxide Synthesis Inhibition Enhanced Antinociception of Morphine in Morphine Tolerant Rats)

  • 송호경;장연
    • The Korean Journal of Pain
    • /
    • 제14권2호
    • /
    • pp.225-230
    • /
    • 2001
  • Background: Opioids such as morphine are widely used in the treatment for pain, but chronic treatment with morphine can be complicated by the development of tolerance. The mechnisms of tolerance were still not completely understood, but recently it has been reported that NOS inhibitors can prevent development of morphine tolerance in animals. The present study accessed the possible role of supraspinal NO on antinociceptive effect of morphine in morphine tolerance using a highly specific inhibitor of the neuronal isoform of NOS, 1-(2-trifluoromethylphenyl) imidazole (TRIM). Methods: Thirty two male SD rats (300 g) were prepared with intracerebroventricular (icv) and IV cannulae. We administrated IV morphine, 3 mg/kg, daily for 4 days, resulting in tolerance. On the fifth day, a challenge dose of morphine, 3 mg/kg, was administered following pretreatment with icv TRIM, $10{\mu}g$. We also evaluated the antinociceptive effect of icv TRIM alone and the effect on a single dose of morphine (3 mg/kg) in morphine nave rats. Antinociception from morphine was determined by response to intraplantar injection of 5% formalin $100{\mu}l$ was qualified as the number of flinches in the first 0-10 min (first phase), 10-40 min Phase IIa, and 40-60 min (Phase IIb). Results: Pretreatment with icv TRIM significantly enhanced the antinociceptive effects of systemically administered morphine in morphine tolerant rats. The antinociceptive effect of morphine in opioid nave rats was also significantly increased by pretreatment with icv TRIM. Conclusions: Our results further support the hypothesis that supraspinal NO modulates morphine-sensitive nociceptive process in morphine tolerance due to chronic intravenous administration.

  • PDF

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats

  • Zhang, Weiqian;Liu, Yan;Ge, Ming;Jing, Jiang;Chen, Yan;Jiang, Huijie;Yu, Hongxiang;Li, Ning;Zhang, Zhigang
    • Nutrition Research and Practice
    • /
    • 제8권2호
    • /
    • pp.220-226
    • /
    • 2014
  • BACKGROUND/OBJECTIVES: Arsenic, which causes human carcinogenicity, is ubiquitous in the environment. This study was designed to evaluate modulation of arsenic induced cancer by resveratrol, a phytoalexin found in vegetal dietary sources that has antioxidant and chemopreventive properties, in arsenic trioxide ($As_2O_3$)-induced Male Wistar rats. MATERIALS/METHODS: Adult rats received 3 mg/kg $As_2O_3$ (intravenous injection, iv.) on alternate days for 4 days. Resveratrol (8 mg/kg) was administered (iv.) 1 h before $As_2O_3$ treatment. The plasma and homogenization enzymes associated with oxidative stress of rat kidneys were measured, the kidneys were examined histologically and trace element contents were assessed. RESULTS: Rats treated with $As_2O_3$ had significantly higher oxidative stress and kidney arsenic accumulation; however, pretreatment with resveratrol reversed these changes. In addition, prior to treatment with resveratrol resulted in lower blood urea nitrogen, creatinine and insignificant renal tubular epithelial cell necrosis. Furthermore, the presence of resveratrol preserved the selenium content ($0.805{\pm}0.059{\mu}g/g$) of kidneys in rats treated with $As_2O_3$. However, resveratrol had no effect on zinc level in the kidney relative to $As_2O_3$-treated groups. CONCLUSIONS: Our data show that supplementation with resveratrol alleviated nephrotoxicity by improving antioxidant capacity and arsenic efflux. These findings suggest that resveratrol has the potential to protect against kidney damage in populations exposed to arsenic.

뇌척수액 미세순환을 통한 래트 내이 외림프의 가돌리늄 조영제 증강 특성 (Enhancement Characteristics of Gadolinium Contrast Agent in the Rat Inner Ear Perilymph through CSF microcirculation)

  • 김민정;이상열;이희중;이태관;장용민
    • 대한의용생체공학회:의공학회지
    • /
    • 제43권4호
    • /
    • pp.193-198
    • /
    • 2022
  • Contrast enhanced magnetic resonance imaging using gadolinium-based contrast agent (GBCA) is a very useful in vivo technique to visualize the inner ear pathology including endolymphatic hydrops. Although systemic intravenous (IV) administration can visualize the perilymph space, the visualization was possible by indirect passage of contrast agent through blood-perilymph barrier. All animal experimental procedures were performed under anesthesia with 5% isoflurane. Lipopolysaccharide (LPS) was instilled into the left tympanic cavity through the tympanic membrane using a sterile 27gauge needle to induce hydrops model. Tucker-Davis Technologies system was used to measure Auditory Brainstem Responses (ABRs). For intracerebroven-tricular (ICV) administration, 25 µmol of GADOVIST (Bayer, Berlin, Germany) was used and diluted GADOVIST injection was 10 µl. MR imaging was acquired with a 9.4 Tesla MRI scanner. Transmit-receive volume coil with 40 mm inner diameter and 75 mm out diameter was used. ICV administration well demonstrated the strong enhancement along the cerebrospinal fluid (CSF) microcirculation pathway including CSF fluid in the subarachnoid space and CSF space of the inner ear structures. On the other hand, IV administration showed no contrast enhancement along the CSF microcirculation pathway and showed weak enhancement in the inner ear structures. In case of rat hydrops model, ICV administration showed that the reduced contrast enhancement in the perilymph space of the hydrops induced inner ear compared to the contrast enhancement in the perilymph space of the normal inner ear. New systemic ICV administration method provide contrast enhancement of GBCA in the inner ear through CSF microcirculation pathway.

식도암의 근치적 치료성적 및 예후인자 (Treatment Result and Prognostic Factors in Pateints with Esophageal Cancer)

  • 정원규;김수곤;김민철;장명;문성록
    • Radiation Oncology Journal
    • /
    • 제13권3호
    • /
    • pp.233-241
    • /
    • 1995
  • Purpose : To analyse clinical outcome and prognostic factors according to treatment modality, this paper report our experience of retrospective study of patients with esophageal cancer Materials and Methods : One hundred and ten patients with primary esophageal cancer who were treated in Presbyterian Medical Center from May 1985 to December 1992. We analysed these patients retrospectively with median follow up time of 28 months, one hundred and four patients($95{\%}$) were followed up from 15 to 69 months. In methods, twenty-eight patients were treated with median radiation dose irradiated 54.3Gy only. Fifty-six patients were treated with combined chemoradiotherapy. Sixteen cases of these patients were treated with concurrent chemoradiation and the other patients(forty cases) were treated sequential chemoradiotherapy. In concurrent chemoradiotherapy group, patients received 5-FU continuous IV infusion for 4 days. Cisplatin IV bolus. and concurrent esophageal irradiation to 30 Gy. After that patients received 5-FU continuous IV, Cisplatin bolus injection and Mitomycin-C bolus IV, Bleomycin continuous IV, and irradiation to 20 Gy. In sequential chemoradiotherapy group, the chemotherapy consisted of 5-FU 1,000mg/$m^2$ administered as a continuous 24 hour intravenous infusion during five days and Cisplatin 80-100mg/$m^2$ bolus injected, or Bleomycin, Vinblastine, Cisplatin, Methotrexate were used of 1 or 2 cycles. After preoperative concurrentm chemoradiation twenty-six patients underwent radical esophagectomy. Results : Ninety-three patients could be examined for response assessment, By treatment modality, response rates were $85.1{\%}$ for radiation alone group and $86.3{\%}$ for combined chemoradiation group. But in operation group, after one cycle of concurrent chemoradiation treatment, response rate was $61.9{\%}$. The pathologic complete response were $15.4{\%}$ in operation group. Overall median survival was II months and actuarial 5-year survival rate was $8{\%}$. The median survival interval was 6 months for radiation alone group, 11 months for combined chemoradiation group and 19 months for operation group. And also median survival was 19 months for complete responder group that 8 months for noncomplete responder group. In univariative analysis, statistically significant prognostic factors were tumor size, clinical stage, tumor response, and operation. In multivariative analysis, significantly better survival was associated with clinical stage, tumor response, radiation dose, and operation. Conclusion : Compared with radiotherapy alone, combined multimodality may improve the median survival in patients with localized carcinoma of the esophagus and toxicity is acceptable.

  • PDF

Involvement of a Novel Organic Cation Transporter in Paeonol Transport Across the Blood-Brain Barrier

  • Gyawali, Asmita;Krol, Sokhoeurn;Kang, Young-Sook
    • Biomolecules & Therapeutics
    • /
    • 제27권3호
    • /
    • pp.290-301
    • /
    • 2019
  • Paeonol has neuroprotective function, which could be useful for improving central nervous system disorder. The purpose of this study was to characterize the functional mechanism involved in brain transport of paeonol through blood-brain barrier (BBB). Brain transport of paeonol was characterized by internal carotid artery perfusion (ICAP), carotid artery single injection technique (brain uptake index, BUI) and intravenous (IV) injection technique in vivo. The transport mechanism of paeonol was examined using conditionally immortalized rat brain capillary endothelial cell line (TR-BBB) as an in vitro model of BBB. Brain volume of distribution (VD) of [$^3H$]paeonol in rat brain was about 6-fold higher than that of [$^{14}C$]sucrose, the vascular space marker of BBB. The uptake of [$^3H$]paeonol was concentration-dependent. Brain volume of distribution of paeonol and BUI as in vivo and inhibition of analog as in vitro studies presented significant reduction effect in the presence of unlabeled lipophilic compounds such as paeonol, imperatorin, diphenhydramine, pyrilamine, tramadol and ALC during the uptake of [$^3H$]paeonol. In addition, the uptake significantly decreased and increased at the acidic and alkaline pH in both extracellular and intracellular study, respectively. In the presence of metabolic inhibitor, the uptake reduced significantly but not affected by sodium free or membrane potential disruption. Similarly, paeonol uptake was not affected on OCTN2 or rPMAT siRNA transfection BBB cells. Interestingly. Paeonol is actively transported from the blood to brain across the BBB by a carrier mediated transporter system.

방사선 조사후 백서 공장 점막의 재생과정에서 5-fluorouracil 투여가 phospholipsse C 와 ras 암유전자단백의 발현에 미치는 영향 (The Influence of 5-Fluorouracil Administration Mode on the Expression of Phospholipase C and Ras Oncoprotein Associated with Regeneration of Rat Intestinal Mucosa Following Radiation)

  • 박경란;이정식;김성숙;이영한;류성호;서판길
    • Radiation Oncology Journal
    • /
    • 제12권3호
    • /
    • pp.271-284
    • /
    • 1994
  • Purpose : Phospholipase C(PLC) isozymes play significant roles in transmembrane signal transduction. PLC-${\gamma}1$ acts as the intracellular effector in signal transduction for cellular proliferation and differentiation. Ras oncoprotein is also involved in cell growth. We determined the biological significance of PLC and ras oncoprotein in regeneration following radiation and the effect of different modes of administration of 5-FU. Materials and Methods : To determine the effect of the administration mode of 5-FU on the regeneration of intestinal mucosa of rats following radiation, we compared the expression of PLC and ras oncoprotein in six groups. Group I had no treatment. Group II received radiation(8 Gy) only. Group III received radiation(8 Gy) and 5-FU(150mg/kg) continuous intravenous (iv) infusion for 12 hours. Group IV received radiation(8 Gy) and 5-FU(750mg/kg) iv bolus injection. Group V received only 5-FU(150mg/kg) continuous iv infusion for 12 hours, Group VI received only 5-FU (150mg/kg) iv bolus injection. Through immunoblotting and immunohistochemistry, we examined the expression of PLC and ras oncoprotein in rat jejunum at 96 hours after radiation or 5-FU administration and at 120 hours after radiation and 5-FU adminstration. We also investigated the histological findings using hematoxylin and eosin stain. Results : In the immunohistochemistry study, PLC-${\gamma}1$ expression was the highest in group III followed by groups II and VI in that order and was weakly positive in groups V and VI. PLC-${\gamma}1$ was hardly detected in the control group. The expression of ras oncoprotein was the same as the PLC-${\gamma}1$ expression for all groups. These results were confirmed by the histological findings regarding the mucosal regeneration. In the immunoblotting analysis, PLC-${\gamma}1$ expression was the highest in group III followed by group IV and II in that order. This difference between the immunoblotting and immunohistochemistry study was due to the high expression of PLC-${\gamma}1$ on the damaged surface epithelium rather than to its expression in the regeneration region as observed in the immunohistochemistry study for group IV. The expression of PLC-${\delta}1$ was positive only in group V and VI, which received both radiation and 5-FU, and the expression of PLC-${\beta}1$ was negligible for all groups. Conclusion : These results suggest that PLC-${\gamma}1$ mediated signal transduetion and ras oncoprotein may have a significant role in mucosal regeneration after radiation, and that continuous iv infusion of 5-FU may induce active regeneration in intestinal mucosa following radiation. In addition, the expression of PLC-${\delta}1$ in combined group of radiation and 5-FU implies that PLC-${\delta}1$ may be involved in signal transduction mediated by concerted action between radiation and 5-FU.

  • PDF

18F-FDG 투여 시 정맥주사 확보 방법 및 생리식염수 용량에 따른 잔류량의 차이에 관한 연구 (Study of the Difference in Residual Amounts according to the Method of Securing Intravenous Injections and the Dose of Physiological Saline during 18F-FDG Administration)

  • 류찬주
    • 한국방사선학회논문지
    • /
    • 제16권2호
    • /
    • pp.95-102
    • /
    • 2022
  • 본 연구는 PET(positron emission tomography) 검사를 위해 내원한 환자를 대상으로 방사성의약품 18F-FDG 동위원소를 주사 할 때, 주사 방법과 생리식염수의 용량에 따른 주사기의 잔량의 차이를 비교하였다. 조영제를 사용하는 CT 혹은 MRI 검사 후, 3-way를 제거하지 않고, PET 검사를 위해 내원한 40명의 환자를 대상으로 18F-FDG를 주사 할 때, 주사기와 3-way에 남게 되는 방사능을 측정하여, 실제 환자에게 투여된 방사능을 확인했다. 이때 20명의 환자들로 나누어 생리식염수의 용량을 달리하였다. 또 다른 주사 방법은 extension을 이용하여 주사 하였을 때, 주사기의 잔량 비교와 생리식염수 용량에 따른 잔량 차이를 비교하였다. 18F-FDG 를 주사 한 후, 주사기와 3-way 또는 extension에 남아 있는 방사능을 검량기로 측정하여 실제 투여된 용량을 확인 했다. 방사성의약품을 투여하기 전의 주사기의 방사능과 투여한 후 주사기와 3-way 또는 extension 의 방사능을 측정한 결과, 생리식염수 10 cc에 3way 의 주입 방식이 잔류량이 가장 낮았고, 생리식염수 10 cc에 extension, 생리식염수 5 cc에 3way 순으로 잔량이 증가하였다. 5 cc의 생리식염수에 extension 주사 방법이 잔량이 가장 많이 남아 있었다. 잔량이 가장 적게 남은 주사 방법과의 잔량 차이는 0.053 mCi이다. PET 검사 시, 3-way와 extension에 남게 되는 방사능을 감안하고, 생리식염수의 투여 용량을 조절함에 따라, 실제 환자에게 투여하고자 하는 목적 용량을 고안한다면 좀 더 정확하게 환자에게 방사성의약품을 투여할 수 있을 것이다.

NICU 간호 숙련성의 차이에 따른 위해 사건 비교 (Comparison of Adverse Events due to Differences in NICU Nursing Expertise)

  • 한영미;성민정;박경희;변신연
    • Neonatal Medicine
    • /
    • 제18권2호
    • /
    • pp.345-352
    • /
    • 2011
  • 목적: 신생아중환자실은 간호 요구도가 높은 곳으로 간호 수준이 환자 결과에 영향을 미치는 것으로 알려져 있다. 저자들은 신생아중환자실에서 간호 숙련성의 차이에 따른 위해 사건의 차이를 비교하고 간호 위해 사건에 대한 예방 지침 마련 후 위해 사건의 변화를 알고자 하였다. 방법: 새로 설립된 A병원과 14 년간 운영되어 온 B병원의 신생아중환자실을 대상으로 2009년 1월 1일부터 2009년 12월 31일 까지 1년간의 간호 위해 사건과 당시 근무한 간호 인력의 경력을 조사하였다. 그리고 A병원에서 간호 위해 사건 예방을 위한 지침을 마련한 후 1년 뒤의 사고 변화를 조사하였다. 결과: A병원의 간호 인력은 2년 이내 경력자가 20명(80%)인 반면 B병원의 간호 인력은 2년 이상 4년 미만의 경력자가 13명(65%)으로 많아 간호 숙련성에 있어 유의한 차이가 있었다(P<0.001). 2009년도에 확인된 간호 위해 사건은 A병원에서 46건, B병원에서 10건으로 전체적으로 A병원에서 많이 발생했고 두 병원에서 정맥주사 관련 사고가 각각 24건(52.2%), 8건(80%)으로 가장 많은 비율을 차지했다. 위해 사건 예방을 위한 간호 지침 마련 후 2010년도에 확인된 간호 위해 사건은 17건으로 총 발생빈도가 감소하였으며 정맥 주사 관련 사고가 6건(35%)으로 가장 많았으나 비율이 감소하였음을 확인하였다. 결론: 간호 숙련성이 높을수록 위해 사건의 빈도가 적었고 위해 사건을 예방하기 위한 지침 마련 후 사고 빈도가 감소함을 확인하였다. 예방 가능한 간호 위해 사건의 빈도를 줄이기 위하여 자체적인 감시와 예방 지침의 강구가 필요하며 이는 중환자실 서비스의 질을 높이는 방법이 될 것이다.